Back to top
Close
Steve Reitmeister

"Today, I Will Give You
5 Stocks to Double Absolutely Free"

Dear Zacks.com Visitor,

I invite you to download a free Special Report that names 5 tickers, each tabbed by a Zacks expert to gain +100% and more in the next 12 months.

The Next Great Innovator looks to change not an industry but an entire economy with earnings expected to skyrocket more than 2,000% in 2015. A recent IPO already has a fortress in its segment. Don't miss these stocks with compelling gain potential.

Merck Kgaa: (MKGAF)

(Market Close from OTC) As of Oct 23, 2014 11:27 AM ET

 Add to portfolio

 ZacksTrade Now

$90.02 USD

90.02

0 (NA%)

Volume: 140

Zacks Rank : 4-Sell [?]       4  

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Quote Overview

Stock Activity

Open 90.02
Day Low 90.02
Day High 90.02
52 Wk Low 85.30
52 Wk High 181.00
Avg. Volume 138
Market Cap 11.63 B
Dividend 0.00 ( 0.00%)
Beta 0.28

Key Earnings Data

Forward PE 15.66
PEG Ratio NA
Current Qtr Est NA
Current Yr Est 5.75
Most Accurate Est NA
Qtr Earnings ESP[?] 0.00%
Exp Earnings Date 11/13/14
Prior Year EPS 7.68
Exp EPS Growth NA
Industry MED-DRUGS

Earnings ESP (Expected Surprise Prediction) is Zacks’ proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement.

Read more about this innovative method in the Zacks Earnings ESP Guide See all the top Earnings ESP Stocks.

Premium Research for MKGAF

Zacks Rank [?] Rank Change Trend Sell 4
Zacks Industry Rank 67 / 265 (Top 25%)
Equity Research Report No Report

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn more about the Zacks Rank

Zacks Rank Home - All Zacks Rank resources in one place

Zacks Premium - The only way to get access to the Zacks Rank

( = Change in last 30 days)

View All Zacks Rank #1 Strong Buys

Learn to Profit from the Zacks Rank

Zacks Recommendation has been removed. Learn more

Due to overwhelming customer feedback we have removed the Zacks Recommendation. Unfortunately, having two separate rating systems proved far too confusing to most investors. Going forward we will just focus on the Zacks Rank which has a longer and more impressive track record of outperformance. Even though the Zacks Rank is primarily used for stock trading in a 1-3 month time frame, it also can be very helpful for long term investors. To learn more about using the Zacks Rank for long term investing, click here.

Premium Research : Industry Analysis

Top Peers Symbol Zacks Rank
MERCK KGAA MKGAF
BIODEL INC BIOD
CEMPRA INC CEMP
IGI LABORATORYS IG
LANNETT INC LCI
PACIRA PHARMACT PCRX
PORTOLA PHARMA PTLA
VALEANT PHARMA VRX
ACELRX PHARMACT ACRX
ALCOBRA LTD ADHD

See all MED-DRUGS Peers>>